Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:December 26, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:December 26, 2018Completed
Condition(s):Giant Cell ArteritisLast Updated:December 2, 2022Completed
Condition(s):COVID-19Last Updated:May 15, 2023Active, not recruiting
Condition(s):Rapid Progressive Interstitial Lung DiseasesLast Updated:January 6, 2022Unknown status
Condition(s):Rheumatoid ArthritisLast Updated:March 6, 2017Completed
Condition(s):Multiple MyelomaLast Updated:June 2, 2023Recruiting
Condition(s):Juvenile Idiopathic ArthritisLast Updated:November 20, 2017Completed
Condition(s):Rheumatoid ArthritisLast Updated:October 28, 2016Completed
Condition(s):Rheumatoid ArthritisLast Updated:January 25, 2023Completed
Condition(s):Breast CancerLast Updated:November 1, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.